Jonathan P. Sleeman

Dr. Jonathan P. Sleeman


Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2006 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
PDF file
JTJean Paul Thiery
Jean Paul Thiery
JSJonathan P. Sleeman
Jonathan P. Sleeman

17 December 2001 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
MGMartin Göttlicher
Martin Göttlicher
SMSaverio Minucci
Saverio Minucci
PZPing Zhu
Ping Zhu
Oliver KrämerOliver Krämer
Oliver Krämer
ASAnnemarie Schimpf
Annemarie Schimpf
THThorsten Heinzel
Thorsten Heinzel
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

7 January 2002 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
CTChristian Termeer
Christian Termeer
FBFrauke Benedix
Frauke Benedix
JSJonathan P. Sleeman
Jonathan P. Sleeman
CFChristina Fieber
Christina Fieber
UVUrsula Voith
Ursula Voith
JSJan Christoph Simon
Jan Christoph Simon
Low molecular weight fragmentation products of the polysaccharide of Hyaluronic acid (sHA) produced during inflammation have been shown to be potent activators of immunocompetent cells such as dendritic cells (DCs) and macrophages. Here we report that sHA induces maturation of DCs via the Toll-like receptor (TLR)-4, a receptor complex associated with innate immunity and host defense against bacterial infection. Bone marrow–derived DCs from C3H/HeJ and C57BL/10ScCr mice carrying mutant TLR-4 alleles were nonresponsive to sHA-induced phenotypic and functional maturation. Conversely, DCs from TLR-2–deficient mice were still susceptible to sHA. In accordance, addition of an anti–TLR-4 mAb to human monocyte–derived DCs blocked sHA-induced tumor necrosis factor α production. Western blot analysis revealed that sHA treatment resulted in distinct phosphorylation of p38/p42/44 MAP-kinases and nuclear translocation of nuclear factor (NF)-κB, all components of the TLR-4 signaling pathway. Blockade of this pathway by specific inhibitors completely abrogated the sHA-induced DC maturation. Finally, intravenous injection of sHA-induced DC emigration from the skin and their phenotypic and functional maturation in the spleen, again depending on the expression of TLR-4. In conclusion, this is the first report that polysaccharide degradation products of the extracellular matrix produced during inflammation might serve as an endogenous ligand for the TLR-4 complex on DCs.

1 December 2002 in Genes & Development
Verified
Journal Article
Open access
PDF file
Véronique Orian-RousseauVéronique Orian-Rousseau
Véronique Orian-Rousseau
LCLinfeng Chen
Linfeng Chen
JSJonathan P. Sleeman
Jonathan P. Sleeman
PHPeter Herrlich
Peter Herrlich
HPHelmut Ponta
Helmut Ponta
The tyrosine kinase receptor c-Met and its ligand HGF/SF, ezrin, and splice variants of CD44 have independently been identified as tumor metastasis-associated proteins. We now show that these proteins cooperate. A CD44 isoform containing variant exon v6 sequences is strictly required for c-Met activation by HGF/SF in rat and human carcinoma cells, in established cell lines as well as in primary keratinocytes. CD44v6-deficient tumor cells were unable to activate c-Met unless they were transfected with a CD44v6-bearing isoform. Antibodies to two v6-encoded epitopes inhibited autophosphorylation of c-Met by interfering with the formation of a complex formed by c-Met, CD44v6, and HGF/SF. In addition, signal transduction from activated c-Met to MEK and Erk required the presence of the cytoplasmic tail of CD44 including a binding motif for ERM proteins. This suggests a role for ERM proteins and possibly their link to the cortical actin cytoskeleton in signal transfer.

1 October 1994 in Current Opinion in Cell Biology
Verified
Journal Article
Closed access
LSLarry Sherman
Larry Sherman
JSJonathan P. Sleeman
Jonathan P. Sleeman
PHPeter Herrlich
Peter Herrlich
HPHelmut Ponta
Helmut Ponta

1 December 2005 in Cancer Research
Verified
Journal Article
Closed access
PDF file
PBPetra Baumann
Petra Baumann
NCNatascha Cremers
Natascha Cremers
FKFrans Kroese
Frans Kroese
GOGertraud Orend
Gertraud Orend
RCRuth Chiquet-Ehrismann
Ruth Chiquet-Ehrismann
JSJonathan P. Sleeman
Jonathan P. Sleeman
The glycosylphosphatidylinositol-anchored membrane protein CD24 functions as an adhesion molecule for P-selectin and L1 and plays a role in B-cell development and neurogenesis. Over the last few years, a large body of literature has also implicated CD24 expression in tumorigenesis and progression. Here, we show that ectopic CD24 expression can be sufficient to promote tumor metastasis in experimental animals. By developing a doxycycline-inducible system for the expression of CD24 in breast cancer cells, we have also analyzed the cellular properties that CD24 expression influences. We found that CD24 expression increased tumor cell proliferation. Furthermore, in addition to promoting binding to P-selectin, CD24 expression also indirectly stimulated cell adhesion to fibronectin, collagens I and IV, and laminin through the activation of α3β1 and α4β1 integrin activity. Moreover, CD24 expression supported rapid cell spreading and strongly induced cell motility and invasion. CD24-induced proliferation and motility were integrin independent. Together, these observations implicate CD24 in the regulation of multiple cell properties of direct relevance to tumor growth and metastasis.